microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. 2009

Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
Integrative Chemical Biology Laboratory, Institute of Molecular Technology, Department of Chemistry, The University of Hong Kong, Pokfulam, Hong Kong, China.

MicroRNAs (miRNAs) are a class of endogenous, small non-protein coding single-stranded RNA molecules, which are crucial post-transcriptional regulators of gene expression. Previous studies have shown that miRNAs participate in a wide range of biological functions and play important roles in various human diseases including glioma. However, the role of miRNAs in mediating glioblastoma cell migration and invasion has not been elucidated. Using miRNA microarray, we identified miR-146b as one of the miRNAs that is significantly dysregulated in human glioblastoma tissue. We showed that miR-146b overexpression by transfection with the precursor miR-146b, or knock-down by Locked Nucleic Acid (LNA)-modified anti-miR-146b, has no effect on the growth of human glioblastoma U373 cells. However, precursor miR-146b transfection significantly reduced the migration and invasion of U373 cells, while LNA-anti-miR-146b transfection generated the opposite result. Furthermore, we discovered that a matrix metalloproteinase gene, MMP16, is one of the downstream targets of miR-146b. Taken together, our findings suggest that miR-146b is involved in glioma cell migration and invasion by targeting MMPs, and implicate miR-146b as a metastasis-inhibiting miRNA in glioma.

UI MeSH Term Description Entries
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
October 2013, Cancer letters,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
September 2017, Oncology reports,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
May 2019, European review for medical and pharmacological sciences,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
April 2017, Oncology reports,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
January 2016, American journal of translational research,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
July 2022, Oncology reports,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
January 2018, OncoTargets and therapy,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
September 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
March 2013, Journal of neuro-oncology,
Hongping Xia, and Yanting Qi, and Samuel S Ng, and Xiaona Chen, and Dan Li, and Shen Chen, and Ruiguang Ge, and Songshan Jiang, and Guo Li, and Yangchao Chen, and Ming-Liang He, and Hsiang-fu Kung, and Lihui Lai, and Marie C Lin
December 2015, Biochemical and biophysical research communications,
Copied contents to your clipboard!